These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 16870690)
1. Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials. Hilbrich L; Sleight P Eur Heart J; 2006 Sep; 27(18):2158-64. PubMed ID: 16870690 [TBL] [Abstract][Full Text] [Related]
2. Ethical dilemmas encountered during clinical drug trials. Daicos GK Hum Health Care; 2001; 1(2):E9. PubMed ID: 14986633 [TBL] [Abstract][Full Text] [Related]
3. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044 [TBL] [Abstract][Full Text] [Related]
4. [Difficulties with conducting clinical trials in France]. Zannad F; Plétan Y Therapie; 2001; 56(4):341-7. PubMed ID: 11677850 [TBL] [Abstract][Full Text] [Related]
5. Specific barriers to the conduct of randomized trials. Duley L; Antman K; Arena J; Avezum A; Blumenthal M; Bosch J; Chrolavicius S; Li T; Ounpuu S; Perez AC; Sleight P; Svard R; Temple R; Tsouderous Y; Yunis C; Yusuf S Clin Trials; 2008; 5(1):40-8. PubMed ID: 18283079 [TBL] [Abstract][Full Text] [Related]